Tandem Diabetes Care (TNDM) Market Capitalization (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Market Capitalization for 14 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Market Capitalization fell 16.64% year-over-year to $1.0 billion; the trailing twelve-month figure through Jun 2026 stood at $1.0 billion (down 16.64% YoY), and the FY2025 full-year result was $1.5 billion, down 37.11% from the prior year.
• Market Capitalization declined to $1.0 billion in Q2 2026 per TNDM's latest filing, from $1.3 billion in the prior quarter.
• Across five years, Market Capitalization topped out at $7.4 billion in Q1 2022 and bottomed at $822.8 million in Q3 2025.
• Historically, Market Capitalization has averaged $2.3 billion across 5 years, with a median of $2.1 billion in 2023.
• The sharpest annual moves came in 2024 and 2025: Market Capitalization surged 105.61% in 2024, then tumbled 70.45% in 2025.
• Over 5 years, Market Capitalization stood at $2.9 billion in 2022, then slumped by 33.13% to $1.9 billion in 2023, then grew by 23.09% to $2.4 billion in 2024, then sank by 37.11% to $1.5 billion in 2025, then sank by 30.09% to $1.0 billion in 2026.
• According to Business Quant data, Market Capitalization over the past three periods registered $1.0 billion, $1.3 billion, and $1.5 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.